Rankings
▼
Calendar
AXGN Q2 2025 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
Q2 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$57M
+18.3% YoY
Gross Profit
$42M
74.2% margin
Operating Income
$2M
3.0% margin
Net Income
$579,000
1.0% margin
EPS (Diluted)
$0.01
QoQ Revenue Growth
+16.7%
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$7M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$205M
Total Liabilities
$93M
Stockholders' Equity
$112M
Cash & Equivalents
$26M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$57M
$48M
+18.3%
Gross Profit
$42M
$35M
+18.9%
Operating Income
$2M
-$428,000
+490.7%
Net Income
$579,000
-$2M
+130.1%
← FY 2025
All Quarters
Q3 2025 →